Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of nicotine mouth spray for smoking cessation
2008-006845-13Phase 3Completed
- Sponsor
- McNeil Laboratories
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nicotine dependence comparing Nicotine mouth spray with Placebo (2 arms). Primary endpoints: Continuous abstinence through week 6, Continuous abstinence through week 24 and 2 more. Started Nov 2008; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2008-006845-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006845-13.